Back
Galectin Therapeutics Vs. Viking Therapeutics Industry Stock Comparison
Sell
47
GALT
Galectin Therapeutics
Last Price:
3.15
Seasonality Move:
-7.91%
Buy
67
VKTX
Viking Therapeutics
Last Price:
69.16
Seasonality Move:
16.7%
Sell
47
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
- The current Galectin Therapeutics [GALT] share price is $3.06. The Score for GALT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $78.01. The Score for VKTX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $3.06
The current trend is relatively stagnant and GALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $78.01
The current trend is moderately bearish and VKTX is experiencing slight buying pressure.
GALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.21 | Sell |
| Chaikin Money Flow: | 88261 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.1 - 3.7) | Sell |
| Bollinger Bands (100): | (1.61 - 3.11) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 57.46 | Buy |
| Chaikin Money Flow: | 1978107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.58 - 77.78) | Buy |
| Bollinger Bands (100): | (26.83 - 77.93) | Buy |
GALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.16 | Sell |
| 20-day SMA: | 3.3 | Sell |
| 50-day SMA: | 2.96 | Buy |
| 200-day SMA: | 2.1 | Buy |
| 8-day EMA: | 3.13 | Sell |
| 20-day EMA: | 3.22 | Sell |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 2.27 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.8 | Buy |
| 20-day SMA: | 73.19 | Buy |
| 50-day SMA: | 72.65 | Buy |
| 200-day SMA: | 32.73 | Buy |
| 8-day EMA: | 75.74 | Buy |
| 20-day EMA: | 74.46 | Buy |
| 50-day EMA: | 68.66 | Buy |
| 200-day EMA: | 41.81 | Buy |
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.
Galectin Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||